Empresa Verona Pharma Plc London S.E.
Acciones
GB00B06GSH43
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- GBX | - |
09/05 | Verona Pharma firma acuerdos de financiación por hasta 650 millones de dólares | MT |
09/05 | Las acciones de Verona Pharma caen tras ampliarse la pérdida del 1T | MT |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 59 | 01/02/20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01/03/20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/19 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/02/19 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01/02/19 |
Corporate Officer/Principal | - | 01/06/20 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01/09/22 |
Caroline Diaz
LAW | General Counsel | - | 01/10/21 |
Matthew Casbon
SAM | Sales & Marketing | - | 24/08/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17/06/16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12/09/16 |
David Ebsworth
CHM | Chairman | 69 | 01/12/14 |
Director/Board Member | 71 | 10/09/15 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01/04/19 |
Director/Board Member | 68 | 10/09/15 | |
Chief Executive Officer | 59 | 01/02/20 | |
Director/Board Member | 59 | 01/09/23 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01/03/21 |
Michael Austwick
BRD | Director/Board Member | 54 | 01/02 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 608 138 246 | 458 671 402 ( 75,42 %) | 0 | 75,42 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,91 % | 109 mil M | |
+10,87 % | 105 mil M | |
+1,28 % | 22,25 mil M | |
-13,14 % | 22,09 mil M | |
-7,05 % | 18,68 mil M | |
-38,36 % | 17,58 mil M | |
-10,66 % | 16,85 mil M | |
+3,75 % | 13,76 mil M | |
+36,70 % | 12,46 mil M |
- Bolsa de valores
- Acciones
- Acción VRNA
- Acción
- Empresa Verona Pharma Plc